Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 8 January 2013
Vol. 6, Issue 257, p. pe1
[DOI: 10.1126/scisignal.2003864]


The Akt DUBbed InAktive

Kui Lin*

Department of Translational Oncology, Research Oncology, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.

Abstract: Akt is a central node in the phosphoinositide-3 kinase–Akt–mammalian target of rapamycin pathway and is activated by a multistep process in response to growth factor stimulation. An additional layer of posttranslational modification has emerged as a new paradigm in the regulation of Akt. The identification of an E3 ligase for Lys63-linked ubiquitination of Akt has now been complemented with the discovery of the tumor suppressor cylindromatosis as a deubiquitinating enzyme (DUB) for Akt. Thus, like phosphorylation and dephosphorylation, cycles of ubiquitination and deubiquitination provide additional on-off switches that keep Akt activity in balance, and disturbances in this balance have pathological consequences.

*Corresponding author. E-mail, klin{at}

Citation: K. Lin, The Akt DUBbed InAktive. Sci. Signal. 6, pe1 (2013).

Read the Full Text

TRAF4 Is a Critical Molecule for Akt Activation in Lung Cancer.
W. Li, C. Peng, M.-H. Lee, D. Lim, F. Zhu, Y. Fu, G. Yang, Y. Sheng, L. Xiao, X. Dong, et al. (2013)
Cancer Res. 73, 6938-6950
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882